{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:02:43Z","timestamp":1791277363195,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.nbd.2012.03.009","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T17:32:36Z","timestamp":1331314356000},"page":"682-691","source":"Crossref","is-referenced-by-count":43,"title":["Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on A\u03b2 accumulation and cell death: Involvement in hippocampal neuronal loss in Alzheimer's disease"],"prefix":"10.1016","volume":"46","author":[{"given":"Desiree","family":"Antequera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bolos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Spuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isidro","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Fernandez-Bachiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Rodr\u00edguez-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Carro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2012.03.009_bb0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","article-title":"Rapid restoration of cognition in Alzheimer's Transgenic Mice with 8-hydroxy quinoline analog is associated with decreased intersticial A\uf062","volume":"59","author":"Adlard","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2012.03.009_bb0010","doi-asserted-by":"crossref","first-page":"e17669","DOI":"10.1371\/journal.pone.0017669","article-title":"Metal ionophore treatment restores dendritic spine density and synaptic protein levels in a mouse model of Alzheimer's disease","volume":"6","author":"Adlard","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2012.03.009_bb0015","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.mcn.2010.07.005","article-title":"Megalin interacts with APP and the intracellular adapter protein FE65 in neurons","volume":"45","author":"Alvira-Botero","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.009_bb0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/hipo.10090","article-title":"Protective role of melatonin in domoic acid-induced neuronal damage in the hippocampus of adult rats","volume":"13","author":"Ananth","year":"2003","journal-title":"Hippocampus"},{"key":"10.1016\/j.nbd.2012.03.009_bb0025","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1021\/jm900628z","article-title":"Neuroprotective and Cholinergic Properties of Multifunctional Glutamic Acid Derivatives for the Treatment of Alzheimer's Disease","volume":"52","author":"Arce","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0030","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0166-2236(00)01659-3","article-title":"Kainate, a double agent that generates seizures: two decades of progress","volume":"23","author":"Ben-Ari","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2012.03.009_bb0035","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00005072-199704000-00010","article-title":"Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease","volume":"56","author":"Bobinski","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.009_bb0040","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.nurt.2008.10.042","article-title":"Memoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's disease","volume":"6","author":"Bolognesi","year":"2009","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.nbd.2012.03.009_bb0045","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","article-title":"Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins","volume":"19","author":"Borchelt","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2012.03.009_bb0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/JAD-2008-15208","article-title":"Drug development based on the metals hypothesis of Alzheimer's disease","volume":"15","author":"Bush","year":"2008","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2012.03.009_bb0055","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1523\/JNEUROSCI.21-15-05678.2001","article-title":"Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy","volume":"21","author":"Carro","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.009_bb0060","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/nm1202-793","article-title":"Serum insulin-like growth factor I regulates brain amyloid-beta levels","volume":"8","author":"Carro","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2012.03.009_bb0070","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.2174\/138161206778792985","article-title":"Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors","volume":"12","author":"Castro","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2012.03.009_bb0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1389557023406610","article-title":"Non-cholinergic pharmacotherapy approaches to the future treatment of Alzheimer's disease","volume":"2","author":"Castro","year":"2002","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0075","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1002\/anie.200700256","article-title":"A small molecule targeting the multifactorial nature of Alzheimer's disease","volume":"46","author":"Cavalli","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.nbd.2012.03.009_bb0080","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1021\/jm7009364","article-title":"Multi-target-directed ligands to combat neurodegenerative diseases","volume":"51","author":"Cavalli","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","article-title":"Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice","volume":"30","author":"Cherny","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2012.03.009_bb0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0024-3205(96)00335-9","article-title":"Amyloidogenic processing of Alzheimer's amyloid precursor protein in vitro and its modulation by metal ions and tacrine","volume":"59","author":"Chong","year":"1996","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2012.03.009_bb0095","doi-asserted-by":"crossref","first-page":"10447","DOI":"10.1021\/bi0101392","article-title":"A structural motif of acetylcholinesterase that promotes amyloid beta-peptide fibril formation","volume":"40","author":"De Ferrari","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2012.03.009_bb0100","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.neurobiolaging.2007.01.008","article-title":"Megalin mediates the transport of leptin across the blood-CSF barrier","volume":"29","author":"Dietrich","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2012.03.009_bb0105","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1021\/bi0272151","article-title":"Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence","volume":"42","author":"Dong","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2012.03.009_bb0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3233\/JAD-2010-1390","article-title":"PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses","volume":"20","author":"Faux","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.nbd.2012.03.009_bb0115","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/cmdc.200800414","article-title":"Tacrine \u2013 Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties","volume":"4","author":"Fern\u00e1ndez-Bachiller","year":"2009","journal-title":"Chem. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0120","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1021\/jm100329q","article-title":"Novel Tacrine \u2013 8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties","volume":"53","author":"Fern\u00e1ndez-Bachiller","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0125","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/j.1471-4159.2006.03960.x","article-title":"Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels","volume":"98","author":"Fu","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0130","first-page":"983","article-title":"Astrocytes containing amyloid beta-protein (Abeta)-positive granules are associated with Abeta40-positive diffuse plaques in the aged human brain","volume":"152","author":"Funato","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.nbd.2012.03.009_bb0135","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000113688","article-title":"Potent \u03b2-Amyloid Modulators","volume":"5","author":"Garc\u00eda-Palomero","year":"2008","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.nbd.2012.03.009_bb0140","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1016\/j.ejmech.2010.09.039","article-title":"Old phenothiazine and dibenzothiadiazepine derivatives for tomorrow's neuroprotective therapies against neurodegenerative diseases","volume":"45","author":"Gonz\u00e1lez-Mu\u00f1oz","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0145","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ejmech.2011.03.003","article-title":"N-Acylaminophenothiazines: neuroprotective agents displaying multifunctional activities for a potential treatment of Alzheimer's disease","volume":"46","author":"Gonz\u00e1lez-Mu\u00f1oz","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0150","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000200013","article-title":"Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimer's disease","volume":"27","author":"Grossberg","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.nbd.2012.03.009_bb0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000287954","article-title":"Effect of huprine X on \u03b2-amyloid, synaptophysin and \u03b17 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice","volume":"7","author":"Hedberg","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.nbd.2012.03.009_bb0160","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1517\/14728222.11.2.161","article-title":"Targeting acetylcholinesterase to treat neurodegeneration","volume":"11","author":"Holzgrabe","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.nbd.2012.03.009_bb0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1196\/annals.1306.012","article-title":"Redox-active metals, oxidative stress, and Alzheimer's disease pathology","volume":"1012","author":"Huang","year":"2004","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.nbd.2012.03.009_bb0170","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1742-4658.2007.06238.x","article-title":"Amyloid-cholinesterase interactions. Implications for Alzheimer's disease","volume":"275","author":"Inestrosa","year":"2008","journal-title":"FEBS J."},{"key":"10.1016\/j.nbd.2012.03.009_bb0175","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1523\/JNEUROSCI.6139-08.2009","article-title":"Ca2+ regulation of dynamin-independent endocytosis in cortical astrocytes","volume":"29","author":"Jiang","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.009_bb0180","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0197-0186(02)00050-5","article-title":"Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets","volume":"41","author":"Klein","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2012.03.009_bb0185","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1474-4422(08)70167-4","article-title":"Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial","volume":"7","author":"Lannfelt","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2012.03.009_bb0190","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1073\/pnas.0712145105","article-title":"A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy","volume":"105","author":"Lee","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2012.03.009_bb0195","doi-asserted-by":"crossref","first-page":"18179","DOI":"10.1074\/jbc.M411085200","article-title":"Novel dimeric acetylcholinesterase inhibitor bis7-tacrine, but not donepezil, prevents glutamate-induced neuronal apoptosis by blocking N-methyl-D-aspartate receptors","volume":"18","author":"Li","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0200","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00005072-199405000-00012","article-title":"Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD)","volume":"53","author":"Mirra","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2012.03.009_bb0205","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.1074\/jbc.M110.172106","article-title":"Lipoprotein lipase is a novel amyloid beta (Abeta)-binding protein that promotes glycosaminoglycan-dependent cellular uptake of Abeta in astrocytes","volume":"286","author":"Nishitsuji","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0210","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.nbd.2011.01.009","article-title":"Clioquinol induces autophagy in cultured astrocytes and neurons by acting as a zinc ionophore","volume":"42","author":"Park","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2012.03.009_bb0215","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/157488907782411774","article-title":"Therapeutic treatment of Alzheimer\u00b4s disease using metal complexing agents","volume":"2","author":"Price","year":"2007","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.nbd.2012.03.009_bb0220","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1001\/jama.280.20.1777","article-title":"Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration","volume":"280","author":"Qizilbash","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2012.03.009_bb0310","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2012.03.009_bb1000","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0197-4580(02)00230-0","article-title":"Acetylcholinesterase promotes beta-amyloid plaques in cerebral cortex","volume":"24","author":"Rees","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2012.03.009_bb0230","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1001\/archneur.60.12.1685","article-title":"Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial","volume":"60","author":"Ritchie","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2012.03.009_bb0235","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/jm050746d","article-title":"Novel tacrine\u2013melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties","volume":"49","author":"Rodr\u00edguez-Franco","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0240","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, proteins, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.nbd.2012.03.009_bb0245","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.pharmtox.43.100901.140248","article-title":"Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics","volume":"43","author":"Selkoe","year":"2003","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2012.03.009_bb0250","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0197-4580(95)00055-J","article-title":"Amyloid, protein (AP) removal by neuroglial cells in culture","volume":"16","author":"Shaffer","year":"1995","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2012.03.009_bb0260","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2146\/ajhp070622","article-title":"Treatment of Alzheimer's disease in the long-term-care setting","volume":"66","author":"Smith","year":"2009","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.nbd.2012.03.009_bb0255","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.bbamem.2007.02.002","article-title":"The redox chemistry of the Alzheimer's disease amyloid beta peptide","volume":"1768","author":"Smith","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2012.03.009_bb0265","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12640-009-9121-2","article-title":"A new tacrine \u2013 melatonin hybrid reduces amyloid burden and behavioral deficits in a mouse model of Alzheimer's disease","volume":"17","author":"Spuch","year":"2010","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2012.03.009_bb0270","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.neuropharm.2006.04.007","article-title":"Acetylcholinesterase inhibitors used in treatment of Alzheimer's disease prevent glutamate neurotoxicity via nicotinic acetylcholine receptors and phosphatidylinositol 3-kinase cascade","volume":"51","author":"Takada-Takatori","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2012.03.009_bb0275","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1523\/JNEUROSCI.21-05-01628.2001","article-title":"Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus","volume":"21","author":"Trejo","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2012.03.009_bb0280","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.neurobiolaging.2008.08.017","article-title":"Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis","volume":"31","author":"Vargas","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2012.03.009_bb0285","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.0013-9580.2004.55403.x","article-title":"CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy","volume":"45","author":"Velez-Pardo","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2012.03.009_bb0290","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer's disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2012.03.009_bb0295","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1747-0285.2009.00925.x","article-title":"In vitro studies on the antioxidant and protective effect of 2-substituted \u22128-hydroxyquinoline derivatives against H(2)O(2)-induced oxidative stress in BMSCs","volume":"75","author":"Wang","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.nbd.2012.03.009_bb0300","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/etc.373","article-title":"Defining and modeling known adverse outcome pathways: Domoic acid and neuronal signaling as a case study","volume":"30","author":"Watanabe","year":"2011","journal-title":"Environ. Toxicol. Chem."},{"key":"10.1016\/j.nbd.2012.03.009_bb0305","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nm838","article-title":"Adult mouse astrocytes degrade amyloid-beta in vitro and in situ","volume":"9","author":"Wyss-Coray","year":"2003","journal-title":"Nat. Med."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112000800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996112000800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T04:06:07Z","timestamp":1561435567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996112000800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0969996112000800"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2012.03.009","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}